High Growth Tech Stocks To Watch In November 2024

In This Article:

In recent weeks, global markets have been buoyed by a strong rally in U.S. stocks, driven by optimism surrounding potential policy shifts following the Republican "red sweep" in the elections. The small-cap Russell 2000 Index notably surged, reflecting investor confidence in anticipated growth and deregulatory measures that could benefit smaller companies. In this context of heightened market activity and economic optimism, identifying high-growth tech stocks involves looking for companies with innovative solutions and robust business models that can capitalize on these favorable conditions to drive future expansion.

Top 10 High Growth Tech Companies

Name

Revenue Growth

Earnings Growth

Growth Rating

Material Group

20.45%

24.01%

★★★★★★

Medley

24.98%

30.36%

★★★★★★

Scandion Oncology

40.71%

75.34%

★★★★★★

TG Therapeutics

34.66%

56.48%

★★★★★★

Pharma Mar

26.94%

56.39%

★★★★★★

Sarepta Therapeutics

23.89%

42.61%

★★★★★★

Alkami Technology

21.89%

98.60%

★★★★★★

Alnylam Pharmaceuticals

22.41%

70.53%

★★★★★★

Adveritas

57.98%

144.21%

★★★★★★

Travere Therapeutics

31.20%

72.26%

★★★★★★

Click here to see the full list of 1280 stocks from our High Growth Tech and AI Stocks screener.

Let's uncover some gems from our specialized screener.

Esprinet

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Esprinet S.p.A. is a company that, along with its subsidiaries, specializes in the wholesale distribution of IT products and consumer electronics across Italy, Spain, Portugal, and other parts of Europe, with a market capitalization of approximately €271.69 million.

Operations: The company generates revenue primarily from the distribution of IT products and consumer electronics, with significant contributions from Italy (€2.57 billion) and the Iberian Peninsula (€1.39 billion). It operates in a competitive market across various European regions, focusing on B2B channels.

Esprinet's recent pivot towards high-margin tech segments is evident from its R&D expenditure, which has strategically focused on enhancing product offerings in competitive markets. With a 4.9% forecasted annual revenue growth, surpassing the Italian market's 4.1%, and a significant earnings surge by 22.6% per year, the company is positioning itself robustly within tech sectors. This shift is underscored by their latest half-year results showing a rebound to EUR 3.25 million in net income from a previous loss, highlighting effective operational adjustments and cost management that are likely to sustain future growth trajectories in an evolving industry landscape.